Article
New York-Adding high-dose vitamin D to docetaxel (Taxotere) in regimens for androgen-independent prostate cancer patients doubles the effectiveness of docetaxel as a single agent, according to results of a nonrandomized study from Oregon Health Sciences University, Portland.
Navigating work-life balance: VUMC’s Family Planning for Surgeons Series
Investigators identify potential dual targets in prostate cancer